NMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer's Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-6190|10|3|272-285

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.10, Iss.3, 2012-09, pp. : 272-285

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NMDA Neurotransmission Dysfunction in Mild Cognitive Impairment and Alzheimer’s Disease

By  

Current Pharmaceutical Design, Vol. 20, Iss. 32, 2014-10 ,pp. : 5169-5179

Bentham Science Publishers

Access to resources Recommend Favorite

Kampo therapy and behavioral and psychological symptoms of dementia

By  

Traditional & Kampo Medicine, Vol. 1, Iss. 2, 2014-12 ,pp. : 11-18

John Wiley & Sons Inc

Access to resources Recommend Favorite

Drug Therapy for Behavioral and Psychological Symptoms of Dementia

By  

Current Neuropharmacology, Vol. 14, Iss. 4, 2016-05 ,pp. : 307-313

Bentham Science Publishers

Access to resources Recommend Favorite

Antipsychotics for the Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD)

By  

Current Neuropharmacology, Vol. 6, Iss. 2, 2008-06 ,pp. : 117-124

Bentham Science Publishers

Access to resources Recommend Favorite

The potential of activation of somatostatinergic neurotransmission with FK960 in Alzheimer’s disease

By Doggrell Sheila A  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 1, 2004-01 ,pp. : 69-72

Informa Healthcare

Access to resources Recommend Favorite